Clinical Trial Update: Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating an intralesional influenza vaccine for treating stage I-IV cutaneous melanoma; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Melanoma

Drugs mentioned

• Intralesional influenza vaccine (influenza vaccine (intralesional))

Snippet

Sponsor: Carlo Contreras | Conditions: Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8 | Phase 1 | Status: RECRUITING